Free, source-traceable HIV knowledge
Menu
AIDS Research CenterEvidence for public health. Knowledge for everyone.
Privacy: no trackingAccessibility StatementSubmit a Correction
AIDS Research CenterEvidence for public health. Knowledge for everyone.SearchLanguageHelp
AIDS Research CenterEvidence for public health. Knowledge for everyone.
English
LanguageEnglishDeutschFrançaisEspañol
Accessibility
Display preferencesStored only on this device.
SavedGet Help

Monitoring

Comorbidity screening

Tests and follow-up used to understand treatment response and long-term health.

Publisher
The Bach Foundation
Audience
Public · Professional · Research
Last reviewed
18 August 2026
Status
Source-linked
Jurisdiction
Global context; local guidance may vary

Essential answer

Comorbidity screening is part of the Center’s monitoring record.

Monitoring connects laboratory results, symptoms, treatment history and preventive care. One result should be interpreted in context and, when necessary, confirmed over time.

Complete public explanation

Tests and follow-up used to understand treatment response and long-term health.

Use the information with its source date, population and jurisdiction. A general explanation cannot determine an individual’s diagnosis, eligibility, regimen or legal obligations.

Key considerations

  • Viral load is the primary measure of treatment suppression.
  • CD4 count reflects immune status but serves a different purpose from viral load.
  • Safety tests and comorbidity screening depend on regimen and individual context.
  • Laboratory reference ranges are not universal diagnoses.

Research and evidence questions

01Which monitoring can be safely simplified after stable suppression?
02How can point-of-care tools expand access?
03Which biomarkers predict long-term outcomes?
04How should results be communicated to support understanding and adherence?

Professional and academic evidence

Professional interpretation of comorbidity screening adds study design, population, comparator, outcomes, statistical methods, limitations, conflicts, guideline adoption, geographic applicability, replication and integrity status.

Evidence record fields for Comorbidity screening
FieldWhat the Center displays
Meaning and scopeDefinition, mechanism, intended use and what should not be inferred.
Population and jurisdictionAge, sex and gender, geography, HIV subtype, clinical context and issuing authority.
OutcomeClinical, virologic, diagnostic, public-health or implementation outcome and follow-up.
ProvenanceOriginal source, identifier, version, funding, conflicts, access date and review.
IntegrityProtocol changes, corrections, expressions of concern, retractions and later evidence.

Principal sources and evidence gateways

Links checked 18 August 2026
01
WHO updated recommendations on HIV clinical managementWorld Health Organization · Guideline · Access checked 18 Aug 2026
02
Clinical guidelines for HIV prevention and treatmentNIH Clinicalinfo · Guideline · Access checked 18 Aug 2026
03
Global HIV & AIDS statistics — 2025 reporting yearUNAIDS · Dataset · Access checked 18 Aug 2026
Additional permanent evidence gateways